AFP and Cirrhosis: Chinese guideline for stratified screening and surveillance of primary liver cancer (2020 Edition) recommends abdominal ultrasonography combined with serum a‐fetoprotein (AFP) every 6 months as a surveillance program for HCC in patients with cirrhosis.9